Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
DERMAdoctor (DDOC) | ThinkEquity (a division of Fordham Financial Management) | 1.88 | $7.00 | $9.00 | $15.00 | n.a. |
Iterum Therapeutics plc (ITRM) | Leerink Partners/ RBC Capital Markets | $92.00 | n.a. | |||
Thunder Bridge Acquisition (TBRGU) (u) | Cantor/ CLSA | 20.00 | $10.00 | $10.00 | $200.00 | n.a. |
n.a. (not available) | ||||||
u (unit offering) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
Alzheon (ALZH) | Citigroup/Piper Jaffray | 5.00 | $13.00 | $15.00 | $70.00 | n.a. |
None | ||||||
New Terms | ||||||
Abpro (ABP) | UBS Investment Bank/ Wells Fargo Securities | 4.00 | $14.00 | $16.00 | $60.00 | S/O |
Carbon Black (CBLK) | Morgan Stanley/ J.P. Morgan | 8.00 | $17.00 | $19.00 | $144.00 | S/O |
Carbon Black (CBLK) | Morgan Stanley/ J.P. Morgan | 8.00 | $17.00 | $19.00 | $144.00 | S/O |
Evelo Biosciences (EVLO) | Morgan Stanley/ Cowen/ BMO Capital Markets | 5.31 | $15.00 | $17.00 | $85.00 | S/O |
HUYA (HUYA) | Credit Suisse/ Goldman Sachs (Asia)/ UBS Investment Bank | 15.00 | $10.00 | $12.00 | $165.00 | S/O |
Inspire Medical Systems (INSP) | BofA Merrill Lynch/ Goldman Sachs | 6.75 | $14.00 | $16.00 | $101.25 | S/O |
S/O (Subscribers Only) | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of April 30, 2018 | Manager(s) | Offered | Raised | Price | 5/4/18 | Change |
Inspire Medical Systems (INSP) | BofA Merrill Lynch/ Goldman Sachs | 6.75 | $108.00 | $16.00 | $24.47 | 52.94% |
Carbon Black (CBLK) | Morgan Stanley/ J.P. Morgan | 8.00 | $152.00 | $19.00 | $23.94 | 26.00% |
BayCom (BCML) | FIG Partners/ D.A. Davidson | 2.85 | $59.88 | $21.00 | $23.00 | 9.52% |
Spirit of Texas Bancshares (STXB) | Stephens/ Keefe, Bruyette & Woods (A Stifel Company) | 2.00 | $42.00 | $21.00 | $21.85 | 4.05% |
Construction Partners (ROAD) | Baird/ Raymond James/ Stephens | 11.25 | $135.00 | $12.00 | $12.10 | 0.83% |
Unity Biotechnology (UBX) | Goldman Sachs/ Morgan Stanley/ Citigroup | 5.00 | $85.00 | $17.00 | $16.75 | -1.47% |
PermRock Royalty Trust (PRT) | Wells Fargo Securities/ Goldman Sachs/ UBS Investment Bank | 6.25 | $106.25 | $17.00 | $15.52 | -8.71% |
ASLAN Pharmaceuticals (ASLN) | Leerink Partners/ Piper Jaffray | 6.00 | $42.18 | $7.03 | $5.61 | -20.20% |